DA32 Life Science Tech Acquisition Corp. (DALS)
Price:
10.30 USD
( - -0.02 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
DESCRIPTION
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
NEWS
Deerfield Management Company, L.P.
gurufocus.com
2023-08-01 22:03:35Deerfield Management Company, L.P. (Series C), a renowned investment firm, recently made a significant addition to its portfolio.
DA32 Life Science Tech Acquisition Corp. Announces Redemption of Shares
businesswire.com
2023-07-21 16:05:00NEW YORK--(BUSINESS WIRE)--DA32 Life Science Tech Acquisition Corp. (Nasdaq: DALS) today announced that its board of directors (the “Board”) has determined to redeem all of its outstanding shares of Class A common stock (the “Public Shares”), effective as of July 28, 2023, because the Company will not consummate an initial business combination within the time period required by its amended and restated certificate of incorporation. As of the close of business on July 28, 2023, the Public Shares.
DA32 Life Science Tech Acquisition Corp., Sponsored by Deerfield, Arch Venture Partners and Section 32, Announces Pricing of $200 Million Initial Public Offering
businesswire.com
2021-07-27 20:37:00NEW YORK--(BUSINESS WIRE)--DA32 Life Science Tech Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 20,000,000 shares of Class A common stock at a price of $10.00 per share. The Class A common stock are expected to be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol "DALS" beginning on July 28, 2021. The offering is expected to close on July 30, 2021. The Company, sponsored by affiliates of Deerfield Management Compan
No data to display
No data to display
Deerfield Management Company, L.P.
gurufocus.com
2023-08-01 22:03:35Deerfield Management Company, L.P. (Series C), a renowned investment firm, recently made a significant addition to its portfolio.
DA32 Life Science Tech Acquisition Corp. Announces Redemption of Shares
businesswire.com
2023-07-21 16:05:00NEW YORK--(BUSINESS WIRE)--DA32 Life Science Tech Acquisition Corp. (Nasdaq: DALS) today announced that its board of directors (the “Board”) has determined to redeem all of its outstanding shares of Class A common stock (the “Public Shares”), effective as of July 28, 2023, because the Company will not consummate an initial business combination within the time period required by its amended and restated certificate of incorporation. As of the close of business on July 28, 2023, the Public Shares.
DA32 Life Science Tech Acquisition Corp., Sponsored by Deerfield, Arch Venture Partners and Section 32, Announces Pricing of $200 Million Initial Public Offering
businesswire.com
2021-07-27 20:37:00NEW YORK--(BUSINESS WIRE)--DA32 Life Science Tech Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 20,000,000 shares of Class A common stock at a price of $10.00 per share. The Class A common stock are expected to be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol "DALS" beginning on July 28, 2021. The offering is expected to close on July 30, 2021. The Company, sponsored by affiliates of Deerfield Management Compan